Industry / Commercial

Founding Life Sciences Partners

The founding Indiana Biosciences Research Institute stakeholders, all global life sciences industry leaders, have come together to  develop interventions, technologies, medicines, and diagnostics to improve metabolic disease and nutrition. The companies research and develop pharmaceuticals, diagnostics, patient health, devices and food technologies that improve the health of patients worldwide. Each has a focus on metabolic disease as well as expertise in a broad spectrum of diseases. This convergence of expertise and research focus creates a collaborative environment only possible at the IBRI where partners will collaborate with each other, academic leaders and healthcare providers to improve human health.  


Cook MedicalCook Medical is the world’s largest private medical device manufacturer, specializing in vascular complications and regenerative medicine.


Dow AgroSciencesDow AgroSciences focuses its research and development on innovative chemical and biotechnology solutions to meet the food, feed, and fiber needs of the world. The company delivers a broad range of technologies in plant genetics and food production, including agricultural chemicals, biotechnology and germplasm.


Eli Lilly and CompanyEli Lilly and Company is a global leader in the development of insulin and diabetes medicines and was the first company to make insulin commercially available. The company continues its leadership position by being the first to bring a wide variety of diabetes advancements to market.  


Indiana University HealthIndiana University Health is a statewide system with more than 20 partner hospitals and health centers throughout Indiana.  As an academic medical center, IU Health is associated with Indiana University School of Medicine, one of the nation's largest medical schools and the site of thousands of research projects and clinical trials.


Roche DiagnosticsRoche Diagnostics, through a complete test portfolio specific to metabolism, as well as through self-testing solutions for patients, is the market leader in diagnosis and monitoring of diabetes and metabolic disorders.